{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:03:03Z","timestamp":1792119783585,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001262","name":"Baily Thomas Charitable Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001262","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Evidence from the UK from the early stages of the covid-19 pandemic showed that people with Intellectual Disabilities (ID) had higher rates of covid-19 mortality than people without ID. However, estimates of the magnitude of risk vary widely; different studies used different time periods; and only early stages of the pandemic have been analysed. Existing analyses of risk factors have also been limited. The objective of this study was to investigate covid-19 mortality rates, hospitalisation rates, and risk factors in people with ID in England up to the end of 2021.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Retrospective cohort study of all people with a laboratory-confirmed SARS-CoV-2 infection or death involving covid-19. Datasets covering primary care, secondary care, covid-19 tests and vaccinations, prescriptions, and deaths were linked at individual level.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Covid-19 carries a disproportionately higher risk of death for people with ID, above their already higher risk of dying from other causes, in comparison to those without ID. Around 2,000 people with ID had a death involving covid-19 in England up to the end of 2021; approximately 1 in 180. The covid-19 standardized mortality ratio was 5.6 [95% CI 5.4, 5.9]. People with ID were also more likely to be hospitalised for covid-19 than people without ID. The main determinants of severe covid-19 outcomes (deaths and\/or hospitalisations) in both populations were age, multimorbidity and vaccination status. The key factor responsible for the higher risk of severe covid-19 in the ID population was a much higher prevalence of multimorbidity in this population. AstraZeneca vaccine was slightly less effective in preventing severe covid-19 outcomes among people with ID than among people without ID.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>People with ID should be considered a priority group in future pandemics, such as shielding and vaccinations.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-023-16993-x","type":"journal-article","created":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T20:34:37Z","timestamp":1698266077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Understanding covid-19 outcomes among people with intellectual disabilities in England"],"prefix":"10.1186","volume":"23","author":[{"given":"Filip","family":"Sosenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill P.","family":"Pell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Hatton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhautesh D.","family":"Jani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Cairns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewy","family":"Nijhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Melville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"CVD-COVID-UK\/COVID-IMPACT Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,25]]},"reference":[{"key":"16993_CR1","unstructured":"Public Health England. Deaths of people identified as having learning disabilities with COVID-19 in England in the spring of 2020. London: Public Health England; 2020. https:\/\/www.gov.uk\/government\/publications\/covid-19-deaths-of-people-with-learning-disabilities."},{"key":"16993_CR2","unstructured":"Office for National Statistics. Updated estimates of coronavirus (COVID-19) related deaths by disability status, England: 24 January to 20 November 2020. Office for National Statistics. 2021. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths\/articles\/coronaviruscovid19relateddeathsbydisabilitystatusenglandandwales\/24januaryto20november2020#data-sources-and-quality."},{"key":"16993_CR3","doi-asserted-by":"publisher","first-page":"n1592","DOI":"10.1136\/bmj.n1592","volume":"374","author":"EJ Williamson","year":"2021","unstructured":"Williamson EJ, McDonald HI, Bhaskaran K, et al. Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform. BMJ. 2021;374:n1592.","journal-title":"BMJ"},{"key":"16993_CR4","doi-asserted-by":"crossref","unstructured":"Clift AK, Coupland CAC, Keogh RH, et al. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. BMJ 2020,371:m3731.","DOI":"10.1136\/bmj.m3731"},{"key":"16993_CR5","doi-asserted-by":"publisher","unstructured":"Henderson A, Fleming M, Cooper S-A, et al. COVID-19 infection and outcomes in a population-based cohort of 17,173 adults with intellectual disabilities compared with the general population. Epub ahead of print 9 February 2021. https:\/\/doi.org\/10.1101\/2021.02.08.21250525.","DOI":"10.1101\/2021.02.08.21250525"},{"key":"16993_CR6","unstructured":"Public Health England. People with Learning Disabilities in England 2015. Public Health England. 2016. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/613182\/PWLDIE_2015_main_report_NB090517.pdf."},{"key":"16993_CR7","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/all.14657","volume":"76","author":"Y-D Gao","year":"2021","unstructured":"Gao Y-D, Ding M, Dong X, et al. Risk factors for severe and critically ill COVID-19 patients: a review. Allergy. 2021;76:428\u201355.","journal-title":"Allergy"},{"key":"16993_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12916-021-01907-8","volume":"19","author":"PM McKeigue","year":"2021","unstructured":"McKeigue PM, Kennedy S, Weir A, et al. Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study. BMC Med. 2021;19:51.","journal-title":"BMC Med"},{"key":"16993_CR9","doi-asserted-by":"publisher","first-page":"e0238091","DOI":"10.1371\/journal.pone.0238091","volume":"15","author":"R McQueenie","year":"2020","unstructured":"McQueenie R, Foster HME, Jani BD, et al. Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort. PLoS One. 2020;15:e0238091.","journal-title":"PLoS One"},{"key":"16993_CR10","doi-asserted-by":"publisher","first-page":"e018292","DOI":"10.1136\/bmjopen-2017-018292","volume":"8","author":"D Kinnear","year":"2018","unstructured":"Kinnear D, Morrison J, Allan L, et al. Prevalence of physical conditions and multimorbidity in a cohort of adults with intellectual disabilities with and without Down syndrome: cross-sectional study. BMJ Open. 2018;8:e018292.","journal-title":"BMJ Open"},{"key":"16993_CR11","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/jir.12775","volume":"64","author":"M McMahon","year":"2020","unstructured":"McMahon M, Hatton C, Bowring DL. Polypharmacy and psychotropic polypharmacy in adults with intellectual disability: a cross-sectional total population study. J Intellect Disabil Res. 2020;64:834\u201351.","journal-title":"J Intellect Disabil Res"},{"key":"16993_CR12","unstructured":"Office for National Statistics. Coronavirus and mortality in England and Wales methodology. Office for National Statistics; 2021. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths\/methodologies\/coronavirusandmortalityinenglandandwalesmethodology#definition-of-covid-19-deaths."},{"key":"16993_CR13","unstructured":"Department of Health and Social Care. Technical report on the COVID-19 pandemic in the UK. Department of Health and Social Care. 2022. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/1128099\/Technical-report-on-the-COVID-19-pandemic-in-the-UK-PRINT.pdf."},{"key":"16993_CR14","unstructured":"Primary Care Domain Reference Set Portal. NHS Digital, https:\/\/digital.nhs.uk\/data-and-information\/data-collections-and-data-sets\/data-collections\/quality-and-outcomes-framework-qof\/quality-and-outcome-framework-qof-business-rules\/primary-care-domain-reference-set-portal. Accessed 8 Aug 2023."},{"key":"16993_CR15","unstructured":"NHS England. Improving identification of people with a learning disability: guidance for general practice. NHS England; 2019. https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2019\/10\/improving-identification-of-people-with-a-learning-disability-guidance-for-general-practice.pdf."},{"key":"16993_CR16","doi-asserted-by":"publisher","first-page":"n826","DOI":"10.1136\/bmj.n826","volume":"373","author":"A Wood","year":"2021","unstructured":"Wood A, Denholm R, Hollings S, et al. Linked electronic health records for research on a nationwide cohort of more than 54 million people in England: data resource. BMJ. 2021;373:n826.","journal-title":"BMJ"},{"key":"16993_CR17","unstructured":"General Practice Extraction Service (GPES) Data for pandemic planning and research: a guide for analysts and users of the data. NHS Digital, https:\/\/digital.nhs.uk\/coronavirus\/gpes-data-for-pandemic-planning-and-research\/guide-for-analysts-and-users-of-the-data. Accessed 20 June 2023."},{"key":"16993_CR18","doi-asserted-by":"publisher","first-page":"e004694","DOI":"10.1136\/bmjopen-2013-004694","volume":"4","author":"C Harrison","year":"2014","unstructured":"Harrison C, Britt H, Miller G, et al. Examining different measures of multimorbidity, using a large prospective cross-sectional study in Australian general practice. BMJ Open. 2014;4:e004694.","journal-title":"BMJ Open"},{"key":"16993_CR19","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.3399\/bjgp18X695465","volume":"68","author":"A Cassell","year":"2018","unstructured":"Cassell A, Edwards D, Harshfield A, et al. The epidemiology of multimorbidity in primary care: a retrospective cohort study. Br J Gen Pract J R Coll Gen Pract. 2018;68:e245\u201351.","journal-title":"Br J Gen Pract J R Coll Gen Pract"},{"key":"16993_CR20","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, et al. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17:230.","journal-title":"BMC Geriatr"},{"key":"16993_CR21","unstructured":"Noble S, McLennan D, Noble M, et al. The English Indices of Deprivation 2019 Research Report. Ministry of Housing, Communities and Local Government; 2019."},{"key":"16993_CR22","unstructured":"Cases in England | Coronavirus in the UK, https:\/\/coronavirus.data.gov.uk\/details\/cases?areaType=nation%26areaName=England#card-variant_percentage_of_available_sequenced_episodes_by_week. Accessed 20 June 2023."},{"key":"16993_CR23","doi-asserted-by":"publisher","first-page":"E107","DOI":"10.1503\/cmaj.190757","volume":"192","author":"RA Payne","year":"2020","unstructured":"Payne RA, Mendonca SC, Elliott MN, et al. Development and validation of the Cambridge multimorbidity score. CMAJ. 2020;192:E107\u201314.","journal-title":"CMAJ"},{"key":"16993_CR24","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1093\/oxfordjournals.aje.a009762","volume":"149","author":"BC Choi","year":"1999","unstructured":"Choi BC, de Guia NA, Walsh P. Look before you leap: stratify before you standardize. Am J Epidemiol. 1999;149:1087\u201396.","journal-title":"Am J Epidemiol"},{"key":"16993_CR25","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/biom.13197","volume":"76","author":"TJ VanderWeele","year":"2020","unstructured":"VanderWeele TJ. Optimal approximate conversions of odds ratios and hazard ratios to risk ratios. Biometrics. 2020;76:746\u201352.","journal-title":"Biometrics"},{"key":"16993_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12982-021-00100-9","volume":"18","author":"E Rahimi","year":"2021","unstructured":"Rahimi E, Hashemi Nazari SS. A detailed explanation and graphical representation of the Blinder-Oaxaca decomposition method with its application in health inequalities. Emerg Themes Epidemiol. 2021;18:12.","journal-title":"Emerg Themes Epidemiol"},{"key":"16993_CR27","unstructured":"Learning from lives and deaths, people with a learning disability and autistic people, https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2020\/05\/easy-read-LeDeR-death-data-end-of-april-22.pdf. Accessed 20 June 2023."},{"key":"16993_CR28","doi-asserted-by":"publisher","first-page":"f7450","DOI":"10.1136\/bmj.f7450","volume":"348","author":"RL Grant","year":"2014","unstructured":"Grant RL. Converting an odds ratio to a range of plausible relative risks for better communication of research findings. BMJ. 2014;348:f7450.","journal-title":"BMJ"},{"key":"16993_CR29","doi-asserted-by":"publisher","first-page":"e052482","DOI":"10.1136\/bmjopen-2021-052482","volume":"11","author":"RA Baksh","year":"2021","unstructured":"Baksh RA, Pape SE, Smith J, et al. Understanding inequalities in COVID-19 outcomes following hospital admission for people with intellectual disability compared to the general population: a matched cohort study in the UK. BMJ Open. 2021;11:e052482.","journal-title":"BMJ Open"},{"key":"16993_CR30","unstructured":"The University of Bristol. Deaths of people with learning disabilities from COVID-19. The University of Bristol; 2020."},{"key":"16993_CR31","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12875-015-0329-3","volume":"16","author":"S-A Cooper","year":"2015","unstructured":"Cooper S-A, McLean G, Guthrie B, et al. Multiple physical and mental health comorbidity in adults with intellectual disabilities: population-based cross-sectional analysis. BMC Fam Pract. 2015;16:110.","journal-title":"BMC Fam Pract"},{"key":"16993_CR32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/jir.12571","volume":"63","author":"F Tyrer","year":"2019","unstructured":"Tyrer F, Dunkley AJ, Singh J, et al. Multimorbidity and lifestyle factors among adults with intellectual disabilities: a cross-sectional analysis of a UK cohort. J Intellect Disabil Res. 2019;63:255\u201365.","journal-title":"J Intellect Disabil Res"},{"key":"16993_CR33","unstructured":"Emerson E, Baines S, Allerton L, et al. Health Inequalities & People F with Learning Disabilities in the UK: 2012. Improving Health and Lives: Learning Disabilities Observatory; 2012. https:\/\/webarchive.nationalarchives.gov.uk\/ukgwa\/20160704171442mp_\/https:\/\/www.improvinghealthandlives.org.uk\/gsf.php5?f=16453&fv=17942."},{"key":"16993_CR34","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1007\/s00415-021-10938-3","volume":"269","author":"JJ Sun","year":"2022","unstructured":"Sun JJ, Perera B, Henley W, et al. Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national study. J Neurol. 2022;269:2750\u201360.","journal-title":"J Neurol"},{"key":"16993_CR35","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1111\/jar.13028","volume":"35","author":"M McMahon","year":"2022","unstructured":"McMahon M, Hatton C, Hardy C, et al. The relationship between subjective socioeconomic status and health in adults with and without intellectual disability. J Appl Res Intellect Disabil. 2022;35:1390\u2013402.","journal-title":"J Appl Res Intellect Disabil"},{"key":"16993_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/10407413.2012.673983","volume":"24","author":"BG Bell","year":"2012","unstructured":"Bell BG, Clegg J. An Ecological approach to reducing the social isolation of people with an intellectual disability. Ecol Psychol. 2012;24:159\u201377.","journal-title":"Ecol Psychol"},{"key":"16993_CR37","doi-asserted-by":"publisher","first-page":"100398","DOI":"10.1016\/j.ccs.2021.100398","volume":"25","author":"P Carnemolla","year":"2021","unstructured":"Carnemolla P, Robinson S, Lay K. Towards inclusive cities and social sustainability: a scoping review of initiatives to support the inclusion of people with intellectual disability in civic and social activities. City Cult Soc. 2021;25:100398.","journal-title":"City Cult Soc"},{"key":"16993_CR38","unstructured":"Office for National Statistics. Coronavirus (COVID-19) Infection Survey technical article: Cumulative incidence of the number of people who have tested positive for COVID-19, UK: Office for National Statistics; 2022. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/conditionsanddiseases\/articles\/coronaviruscovid19infectionsurveytechnicalarticlecumulativeincidenceofthenumberofpeoplewhohavetestedpositiveforcovid19uk\/22april2022\/pdf."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-16993-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-023-16993-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-16993-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T05:21:10Z","timestamp":1700371270000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-023-16993-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,25]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["16993"],"URL":"https:\/\/doi.org\/10.1186\/s12889-023-16993-x","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,25]]},"assertion":[{"value":"21 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The North East\u2014Newcastle and North Tyneside 2 research ethics committee provided ethical approval for the CVD-COVID-UK\/COVID-IMPACT research programme (REC No 20\/NE\/0161) to access, within secure trusted research environments, unconsented, whole-population, de-identified data from electronic health records collected as part of patients\u2019 routine healthcare. The need for informed consent was waived by the North East\u2014Newcastle and North Tyneside 2 research ethics committee. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2099"}}